• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

β-磷酸三钙在良性肿瘤术后骨缺损中的应用的临床结果。

Clinical Outcome of Beta-Tricalcium Phosphate Use for Bone Defects after Operative Treatment of Benign Tumors.

机构信息

Department of Orthopedic Surgery, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea.

出版信息

Clin Orthop Surg. 2019 Jun;11(2):233-236. doi: 10.4055/cios.2019.11.2.233. Epub 2019 May 9.

DOI:10.4055/cios.2019.11.2.233
PMID:31156777
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6526132/
Abstract

BACKGROUND

We investigated the clinical outcome in patients whose cavitary bone defects were treated with beta-tricalcium phosphate (β-TCP) after surgical removal of benign tumors.

METHODS

Between March 2015 and December 2015, 20 patients who underwent operation for bone tumors were enrolled into this study and prospectively followed up for a median period of 28.1 months.

RESULTS

When the radiographic sign of complete resorption was defined as greater than 50% resorption of the allograft material accompanied by bone remodeling until 12 months, 55% of patients had complete resorption. Positive correlation between the filling volume and time needed for complete resorption was not found ( = 0.184).

CONCLUSIONS

Purified β-TCP could be a suitable choice as a bone graft substitute after the removal of benign bone tumors.

摘要

背景

我们研究了在良性肿瘤切除术后使用β-磷酸三钙（β-TCP）治疗腔隙性骨缺损患者的临床结果。

方法

2015 年 3 月至 2015 年 12 月期间，我们对 20 例因骨肿瘤接受手术的患者进行了前瞻性研究，并进行了中位数为 28.1 个月的随访。

结果

当将完全吸收的影像学标志定义为大于 50%的同种异体材料吸收，伴有骨重建，直至 12 个月时，55%的患者有完全吸收。填充体积与完全吸收所需时间之间无正相关关系（=0.184）。

结论

在良性骨肿瘤切除术后，纯化的β-TCP 可作为一种合适的骨移植替代物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9034/6526132/a87e811eeb67/cios-11-233-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9034/6526132/28d80f1ea5d1/cios-11-233-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9034/6526132/19d0946284de/cios-11-233-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9034/6526132/a87e811eeb67/cios-11-233-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9034/6526132/28d80f1ea5d1/cios-11-233-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9034/6526132/19d0946284de/cios-11-233-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9034/6526132/a87e811eeb67/cios-11-233-g003.jpg

相似文献

1
Clinical Outcome of Beta-Tricalcium Phosphate Use for Bone Defects after Operative Treatment of Benign Tumors.β-磷酸三钙在良性肿瘤术后骨缺损中的应用的临床结果。
Clin Orthop Surg. 2019 Jun;11(2):233-236. doi: 10.4055/cios.2019.11.2.233. Epub 2019 May 9.
2
Effectiveness of ultraporous β-tricalcium phosphate (vitoss) as bone graft substitute for cavitary defects in benign and low-grade malignant bone tumors.超微孔β-磷酸三钙（Vitoss）作为骨移植替代物用于良性和低级别恶性骨肿瘤空洞性缺损的有效性。
Am J Orthop (Belle Mead NJ). 2012 Jan;41(1):20-3.
3
Ultraporous β-tricalcium phosphate alone or combined with bone marrow aspirate for benign cavitary lesions: comparison in a prospective randomized clinical trial.单纯超多孔 β-磷酸三钙或联合骨髓抽吸治疗良性囊性病变：前瞻性随机临床试验比较。
J Bone Joint Surg Am. 2013 Jan 16;95(2):158-66. doi: 10.2106/JBJS.K.00181.
4
Ultraporous beta-tricalcium phosphate is well incorporated in small cavitary defects.超多孔β-磷酸三钙能很好地融入小的空洞性缺损中。
Clin Orthop Relat Res. 2005 May(434):251-7. doi: 10.1097/01.blo.0000153991.94765.1b.
5
Use of purified beta-tricalcium phosphate for filling defects after curettage of benign bone tumours.使用纯化的β-磷酸三钙填充良性骨肿瘤刮除术后的缺损。
Int Orthop. 2006 Dec;30(6):510-3. doi: 10.1007/s00264-006-0156-1. Epub 2006 May 31.
6
Bone healing and graft resorption of autograft, anorganic bovine bone and beta-tricalcium phosphate. A histologic and histomorphometric study in the mandibles of minipigs.自体骨、无机牛骨和β-磷酸三钙的骨愈合及移植物吸收：小型猪下颌骨的组织学和组织形态计量学研究
Clin Oral Implants Res. 2006 Jun;17(3):237-43. doi: 10.1111/j.1600-0501.2005.01257.x.
7
Cone Beam Computed Tomography Assessment of Maxillary Sinus Floor Augmentation Using Beta-Tricalcium Phosphate Alone or in Combination with Platelet-Rich Plasma: A Randomized Clinical Trial.使用单纯β-磷酸三钙或联合富血小板血浆进行上颌窦底提升的锥形束计算机断层扫描评估：一项随机临床试验
Int J Oral Maxillofac Implants. 2016 Nov/Dec;31(6):1367-1375. doi: 10.11607/jomi.5205.
8
A new β-tricalcium phosphate with uniform triple superporous structure as a filling material after curettage of bone tumor.一种新型的β-磷酸三钙，具有均匀的三重超微孔结构，可用作骨肿瘤刮除术后的填充材料。
Anticancer Res. 2013 Nov;33(11):5075-81.
9
Filling bone defects with β-TCP in maxillofacial surgery: A review.颌面外科中使用β-磷酸三钙填充骨缺损：综述
Morphologie. 2017 Sep;101(334):113-119. doi: 10.1016/j.morpho.2017.05.002. Epub 2017 May 29.
10
Intraosseous lipoma: a report of two cases with use of tricalcium phosphate bone void filler.骨内脂肪瘤：两例应用磷酸三钙骨缺损填充剂的报告。
J Am Podiatr Med Assoc. 2010 Nov-Dec;100(6):487-92. doi: 10.7547/1000487.

引用本文的文献

1
Personalized 3D-Printed Prostheses for Bone Defect Reconstruction After Tumor Resection in the Foot and Ankle.用于足踝部肿瘤切除术后骨缺损重建的个性化3D打印假体
J Funct Biomater. 2025 Feb 11;16(2):62. doi: 10.3390/jfb16020062.
2
Exploring the Biological Impact of β-TCP Surface Polarization on Osteoblast and Osteoclast Activity.探索β-磷酸三钙表面极化对成骨细胞和破骨细胞活性的生物学影响。
Int J Mol Sci. 2024 Dec 27;26(1):141. doi: 10.3390/ijms26010141.
3
Efficacy and Safety of Beta-Tricalcium Phosphate/Polylactic-Co-Glycolic Acid for Implantation of Bone Defects.

本文引用的文献

1
Use of purified beta-tricalcium phosphate for filling defects after curettage of benign bone tumours.使用纯化的β-磷酸三钙填充良性骨肿瘤刮除术后的缺损。
Int Orthop. 2006 Dec;30(6):510-3. doi: 10.1007/s00264-006-0156-1. Epub 2006 May 31.
2
Bone graft substitutes.骨移植替代物。
Expert Rev Med Devices. 2006 Jan;3(1):49-57. doi: 10.1586/17434440.3.1.49.
3
Promotion of bone formation using highly pure porous beta-TCP combined with bone marrow-derived osteoprogenitor cells.使用高纯度多孔β-磷酸三钙联合骨髓来源的骨祖细胞促进骨形成。
β-磷酸三钙/聚乳酸-羟基乙酸共聚物用于骨缺损植入的有效性和安全性
Cureus. 2023 Aug 16;15(8):e43597. doi: 10.7759/cureus.43597. eCollection 2023 Aug.
4
β-TCP/S53P4 Scaffolds Obtained by Gel Casting: Synthesis, Properties, and Biomedical Applications.通过凝胶浇铸法制备的β-磷酸三钙/S53P4支架：合成、性能及生物医学应用
Bioengineering (Basel). 2023 May 16;10(5):597. doi: 10.3390/bioengineering10050597.
5
Injectable Synthetic Beta-Tricalcium Phosphate/Calcium Sulfate (GeneX) for the Management of Contained Defects Following Curettage of Benign Bone Tumours.可注射合成β-磷酸三钙/硫酸钙（GeneX）在良性骨肿瘤刮除术后的含腔缺损治疗中的应用。
Curr Oncol. 2023 Mar 27;30(4):3697-3707. doi: 10.3390/curroncol30040281.
6
Bone Regeneration by Multichannel Cylindrical Granular Bone Substitute for Regeneration of Bone in Cases of Tumor, Fracture, and Arthroplasty.多通道圆柱状颗粒状骨替代物在肿瘤、骨折和关节置换病例中的骨再生
Int J Environ Res Public Health. 2022 Jul 6;19(14):8228. doi: 10.3390/ijerph19148228.
7
Correlation between two-dimensional micro-CT and histomorphometry for assessment of the implant osseointegration in rabbit tibia model.二维显微CT与组织形态计量学在兔胫骨模型中评估种植体骨整合的相关性
Biomater Res. 2021 Apr 13;25(1):11. doi: 10.1186/s40824-021-00213-x.
Biomaterials. 2002 Dec;23(23):4493-502. doi: 10.1016/s0142-9612(02)00193-x.
4
Beta-tricalcium phosphate ceramic as a bone substitute in orthopaedic surgery.β-磷酸三钙陶瓷作为骨科手术中的骨替代物。
Int Orthop. 2002;26(2):109-15. doi: 10.1007/s00264-001-0329-x.
5
The role of the osteoconductive scaffold in synthetic bone graft.骨传导支架在合成骨移植中的作用。
Orthopedics. 2002 May;25(5 Suppl):s571-8. doi: 10.3928/0147-7447-20020502-05.
6
Nonallograft osteoconductive bone graft substitutes.非同种异体骨传导性骨移植替代物。
Clin Orthop Relat Res. 2002 Feb(395):44-52. doi: 10.1097/00003086-200202000-00006.
7
Complications of iliac crest bone graft harvesting.髂嵴取骨的并发症。
Clin Orthop Relat Res. 1996 Aug(329):300-9. doi: 10.1097/00003086-199608000-00037.
8
Role of bone substitutes.骨替代物的作用。
Clin Orthop Relat Res. 1996 Mar(324):55-65. doi: 10.1097/00003086-199603000-00008.
9
Granular tricalcium phosphate grafting of cavitary lesions in human bone.人骨空洞性病变的颗粒状磷酸三钙移植
Clin Orthop Relat Res. 1994 Sep(306):197-203.
10
Iliac crest bone graft harvest donor site morbidity. A statistical evaluation.髂嵴取骨供区并发症。一项统计学评估。
Spine (Phila Pa 1976). 1995 May 1;20(9):1055-60. doi: 10.1097/00007632-199505000-00012.